Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate Patients
NCT ID: NCT02329509
Last Updated: 2016-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2010-01-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study hypothesis states that a two stage cleft palate repair , with a late hard palate repair will reduce maxillary growth impairment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Articulation and Phonology in Children With Unilateral Cleft Lip and Palate
NCT00829101
Cleft Palate Surgery and Speech Development
NCT00004639
Early Intervention in Infants With Unrepaired Cleft Palate: Language, Palatal Function, and Articulation.
NCT07219901
An Investigation for the Optimal Timing of a Cleft Palate Repair
NCT00779961
Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate
NCT05081258
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The groups are numbered in post op care attendance of the lip repair, according to randomization sequence done in computerized statistical program. The randomization is being held after the first month of the lip repair surgery. The surgeon, and parents or guardians (who have already signed the Informed Consent Form) will not have prior access to information on the type of allocation in each group. Subsequently it will be added in patients chart the record set for the patient group.
\>Study Variables Independent variables:. Group I (palate closure in two surgical times and GII (closure of the palate in a surgical time) also will be considered independent variables age, sex, birth weight and maternal education.
Dependent variables: the presence of postoperative infection, initial and intermediate cleft sizes, dimensional changes of the transverse arch, the evaluation indexes of dental arch relationship(Goslom,Atack Yardsticks) and speech outcomes evaluation grades
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
one stage cleft palate surgery
Subjects submitted to one stage palate surgical repair after 9 months old and before 24 months old ,
One stage Palate Surgical repair
One stage palate repair at the age of 9 to 24 months old
two stage palate repair
Subjects submitted to two stage palate surgical repair (first soft palate repair between 6 and 12 months old and hard palate closure at 3 to 4 years old)
two stage palate surgical repair
two stage palate surgical repair with a hard palate closure at 3 to 4 years old
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
two stage palate surgical repair
two stage palate surgical repair with a hard palate closure at 3 to 4 years old
One stage Palate Surgical repair
One stage palate repair at the age of 9 to 24 months old
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients without clinical conditions for performing the surgical chronology protocol;
* Patients whose parents or guardians who are not in accordance with the Informed Consent Statement proposed by the researcher
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Professor Fernando Figueira Integral Medicine Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rui Manuel Rodrigues Pereira
CADEFI Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nivaldo Alonso, PH.D
Role: STUDY_DIRECTOR
USP
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CADEFI /IMIP
Identifier Type: OTHER
Identifier Source: secondary_id
U1111-1158-3755
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.